Catalent Investor Relations Material
Latest events
Investor Update
Catalent
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Catalent Inc
Access all reports
Catalent, Inc. is a global contract development and manufacturing organization and provider of research, analytical and clinical services. Catalent offers integrated discovery, development and manufacturing solutions including late stage clinical, sterile process design, commercial production and development solutions for biologics and over-the-counter health drug products.
The company also provides comprehensive pharmaceutical services through established early phase development capabilities in small molecule API drug development and late phase clinical development capabilities in global multi-site clinical trials. In addition to biopharmaceuticals and OTC services, Catalent provides an integrated suite of R&D services, including protein chemistry and analytical testing to support non-biotechnology clients developing diagnostics for use in the clinical laboratory. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CTLT
Country
🇺🇸 United States